发明申请
US20150203481A1 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
审中-公开
新型杂环衍生物及其在神经障碍治疗中的应用
- 专利标题： Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
- 专利标题（中）： 新型杂环衍生物及其在神经障碍治疗中的应用
-
申请号： US14482662申请日： 2014-09-10
-
公开(公告)号： US20150203481A1公开(公告)日： 2015-07-23
- 发明人: Sangamesh BADIGER , Murali CHEBROLU , Konstanze HURTH , Sebastien JACQUIER , Rainer Martin LUEOEND , Rainer MACHAUER , Heinrich RUEEGER , Marina TINTELNOT-BLOMLEY , Siem Jacob VEENSTRA , Markus VOEGTLE
- 申请人： Sangamesh BADIGER , Murali CHEBROLU , Konstanze HURTH , Sebastien JACQUIER , Rainer Martin LUEOEND , Rainer MACHAUER , Heinrich RUEEGER , Marina TINTELNOT-BLOMLEY , Siem Jacob VEENSTRA , Markus VOEGTLE
- 申请人地址： CH Basel
- 专利权人： NOVARTIS AG
- 当前专利权人： NOVARTIS AG
- 当前专利权人地址： CH Basel
- 优先权： IN77/DEL/2011 20110113
- 主分类号： C07D413/14
- IPC分类号： C07D413/14 ; C07D487/04 ; C07D471/04 ; A61K31/5377
摘要：
The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.
公开/授权文献
信息查询
